Alternate home page
Urgent advice: Surgery Building & Improvements
Polite notice for all our patients and visitors who may attend the surgery between 25th November 2024 & 13th Janurary 2025.
We have scheduled building works & improvements in the surgery and although we don't expect this to cause any distruption to surgery services during this time, there will be some noise on site while these improvements are completed.
We thank you for your understandingand apologise for any inconvienceduring this period.
Non-urgent advice: Welcome to Hampton Medical Centre
Hampton Medical Centre is a primary care General Practice provider situated in the heart of Hampton, Peterborough.
Our practrice is made up of General Practitioners, Advanced Clinical Practitioners, Advanced Nurse Practitioners, Paramedics, Physician Associates, Clinical Pharmacists and Nurses.
We are one of the few practices to be registered as a teaching practice, to provide a supervised learning environment for the training of medical students. We also provide General Practitioner Registrar training opportunities.
We form part of the Cambridgeshire & Peterborough Integrated Care Board and are commissioned by them to provide NHS services.
Latest News
Winter 2024/25 Flu/COVID Vaccine
The main flu and COVID-19 vaccination campaign will commence on Thursday 3 October 2024.
Flu Eligability:
- pregnant women
- all children aged 2 or 3 years on 31 August 2024
- primary school aged children (from Reception to Year 6)
- secondary school aged children (from Year 7 to Year 11)
- all children in clinical risk groups aged from 6 months to less than 18 years
- those aged 65 years and over
- those aged 18 years to under 65 years in clinical risk groups
- those in long-stay residential care homes
- carers in receipt of carer’s allowance, or those who are the main carer of an elderly or disabled person
- close contacts of immunocompromised individuals
The surgery will be running clinics and will invite those eligible nearer the vaccination schedule time.
RSV Vaccine
Respiratory syncytial virus (RSV) is an RNA virus which is a common cause of respiratory tract infections. It usually causes a mild self-limiting respiratory infection in adults and children but can be severe in infants and older adults who are at increased risk of acute lower respiratory tract infection.
RSV infects up to 90% of children within the first 2 years of life and frequently reinfects older children and adults.
For most people, RSV infection causes a mild respiratory illness with a range of symptoms such as rhinitis (runny nose, sneezing or nasal congestion), cough, shortness of breath, fever, lethargy and decreased appetite.
An RSV vaccine should be offered to:
- adults aged 75 years old on or after 1 September 2024, who remain eligible until their 80th birthday
- all pregnant women from 28 weeks’ gestation
Eligible individuals will have been born on or after 1 September 1949 and become eligible on their birthday (not before).
A BSL video is available here.